<?xml version="1.0" encoding="UTF-8"?>
<p id="Par55">A total of 1199 HCV-infected patients (1081 HCV-monoinfected and 118 HCV/HIV-coinfected) initiated DAAs during the study period. A total of 144/1199 subjects (12.0%) presented psychiatric comorbidities and were included in the study, of whom 101 (70.1%) were on anxiolytic/antidepressant therapy (group A) and the remaining 43 (29.9%) were treated with antipsychotic drugs (group B). In Fig.Â 
 <xref rid="Fig1" ref-type="fig">1</xref> is represented the study diagram. 
</p>
